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Introduction

➢ With the increase in number of immunocompromised patients,
there has been an increase in unusual manifestations of
aggressive fungal infections like invasive rhinosinusitis. Patients
are often older, only mildly immunocompromised, and have a
history of recent nasal/sinus interventions or intranasal cocaine
use.

Presentation

❖Chronic rhinosinusitis for months
❖Visual changes from orbital involvement
❖Neurological complaints due to brain and CN involvement
❖Physical examination may reveal tenderness over the maxillary
sinuses, erythema overlying the malar areas, proptosis or fixation
of the globe
Microbiology: Aspergillus spp and brown-black molds are more
common causes, not the Mucorales

Case

Imaging & Surgical pathology
MRI brain and face (Fig 1.)
➢ Expansile mass at the left pterygopalatine fossa with extension
into the pterygoid muscle/masticator space
➢ Thickening of V2 and V3, concerning for malignancy.
CT angiogram of head and neck
➢ polypoidal mucosal thickening of the left maxillary and sphenoid
sinus without hyper vascularity to suggest malignancy.
Imaging may show
❖Involvement of a single paranasal sinus with a mass lesion and
thickening of the mucosa.
❖Bony erosions in invasive disease are most likely to seen by CT
Endonasal resection and surgical biopsy
➢ Granulomatous inflammation with fungal elements consistent
with Mucorales.

A 61-year-old construction worker with past medical history of type
2 Diabetes Mellitus, Essential hypertension presented initially in the
ENT clinic with five-months of left-sided facial numbness (left alar to
the infraorbital region to the left side of his lip) and tingling inside
his left nasal cavity. Symptoms started two weeks after septoplasty
for correction of deviated nasal septum. Patient did not have any
features of chronic rhinosinusitis. Of note, his HBA1C five months
before and one month after the procedure was 9.9 and 13.6,
respectively. Lab work did not show evidence of hematological
disorders.

Discussion

Recently, diabetes mellitus/hyperglycemia has become a common risk
factor for acute/chronic invasive fungal sinus infections. Patients with
suspected fungal sinusitis should get
❖Early nasal endoscopy with biopsies of the affected tissue. Ample
tissue should be obtained, including tissues from viable areas to
detect vascular invasion and morphology of the fungus.
❖Biopsy specimens should be evaluated intraoperatively to assure
sufficient diagnostic tissue is obtained.
❖Histopathologic findings from the surgical specimen can guide initial
treatment until culture results return.
❖Cultures are usually positive but can have false negative result due to
fastidious nature of Mucorales.

Follow up and prognosis

➢ Patient was treated with oral Posaconazole for 6 months, symptoms
improved
➢ Follow MRI of the brain and face (Fig 3)
o Extent of enhancing tissue is similar but nodular components have
slight decreased in size with improvement of hard palate/maxillary
alveolus enhancement.
o Marked polypoid mucosal thickening of the left maxillary sinus and
ethmoid air cells, progressed from before
Overall survival is poor, and long-term survivors may have significant
sinonasal complications, especially when there is intracranial
involvement and cranial neuropathies at presentation.

Fig 2. Histopathologic demonstration of septate hyphae of Mucorales

Treatment and hospital course

Patient was admitted to the hospital for IV antifungals. He was
treated with Lipid formulation of Amphotericin B (5 mg/kg per day)
for 4 weeks followed Posaconazole.
Hospital stay complicated by development of acute kidney injury.
Sensation of the left side of the face begin to improve with initiation
of antifungals.
Initial therapy
➢ Liposomal Amphotericin B: Duration depends on underlying
immune status of the host, extent of surgical debridement and
the response to therapy
➢ Then suppressive therapy with oral antifungal: Posaconazole or
Isavuconazole

Fig 3. MRI of brain and face after treatment
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❖Invasive rhinosinusitis is a very difficult infection to cure as most
affected patients are immunocompromised.
❖Role of hyperbaric therapy or iron chelation is uncertain
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